Cargando…
Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model
BACKGROUND: A direct contact transmission challenge model was used to simulate natural foot-and-mouth disease virus (FMDV) spread from FMDV A24/Cruzeiro/BRA/55 infected ‘seeder’ steers to naïve or vaccinated steers previously immunized with a replication-deficient human adenovirus-vectored FMDV A24/...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114537/ https://www.ncbi.nlm.nih.gov/pubmed/30157853 http://dx.doi.org/10.1186/s12917-018-1582-1 |
_version_ | 1783351212725239808 |
---|---|
author | Neilan, John G. Schutta, Christopher Barrera, José Pisano, Melia Zsak, Laszlo Hartwig, Ethan Rasmussen, Max V. Kamicker, Barbara J. Ettyreddy, Damodar Brough, Douglas E. Butman, Bryan T. Brake, David A. |
author_facet | Neilan, John G. Schutta, Christopher Barrera, José Pisano, Melia Zsak, Laszlo Hartwig, Ethan Rasmussen, Max V. Kamicker, Barbara J. Ettyreddy, Damodar Brough, Douglas E. Butman, Bryan T. Brake, David A. |
author_sort | Neilan, John G. |
collection | PubMed |
description | BACKGROUND: A direct contact transmission challenge model was used to simulate natural foot-and-mouth disease virus (FMDV) spread from FMDV A24/Cruzeiro/BRA/55 infected ‘seeder’ steers to naïve or vaccinated steers previously immunized with a replication-deficient human adenovirus-vectored FMDV A24/Cruzeiro/BRA/55 capsid-based subunit vaccine (AdtA24). In two independent vaccine efficacy trials, AdtA24 was administered once intramuscularly in the neck 7 days prior to contact with FMDV A24/Cruzeiro/BRA/55-infected seeder steers. RESULTS: In Efficacy Study 1, we evaluated three doses of AdtA24 to estimate the 50%/90% bovine protective dose (BPD(50/90)) for prevention of clinical FMD. In vaccinated, contact-challenged steers, the BPD(50/90) was 3.1 × 10(10) / 5.5 × 10(10) AdtA24 particles formulated without adjuvant. In Efficacy Study 2, steers vaccinated with 5 × 10(10) AdtA24 particles, exposed to FMDV A24/Cruzeiro/BRA/55-infected seeder steers, did not develop clinical FMD or transmit FMDV to other vaccinated or naïve, non-vaccinated steers. In contrast, naïve, non-vaccinated steers that were subsequently exposed to FMDV A24/Cruzeiro/BRA/55-infected seeder steers developed clinical FMD and transmitted FMDV by contact to additional naïve, non-vaccinated steers. The AdtA24 vaccine differentiated infected from vaccinated animals (DIVA) because no antibodies to FMDV nonstructural proteins were detected prior to FMDV exposure. CONCLUSIONS: A single dose of the AdtA24 non-adjuvanted vaccine conferred protection against clinical FMD at 7 days post-vaccination following direct contact transmission from FMDV-infected, naïve, non-vaccinated steers. The AdtA24 vaccine was effective in preventing FMDV transmission from homologous challenged, contact-exposed, AdtA24-vaccinated, protected steers to co-mingled, susceptible steers, suggesting that the vaccine may be beneficial in reducing both the magnitude and duration of a FMDV outbreak in a commercial cattle production setting. |
format | Online Article Text |
id | pubmed-6114537 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61145372018-09-04 Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model Neilan, John G. Schutta, Christopher Barrera, José Pisano, Melia Zsak, Laszlo Hartwig, Ethan Rasmussen, Max V. Kamicker, Barbara J. Ettyreddy, Damodar Brough, Douglas E. Butman, Bryan T. Brake, David A. BMC Vet Res Research Article BACKGROUND: A direct contact transmission challenge model was used to simulate natural foot-and-mouth disease virus (FMDV) spread from FMDV A24/Cruzeiro/BRA/55 infected ‘seeder’ steers to naïve or vaccinated steers previously immunized with a replication-deficient human adenovirus-vectored FMDV A24/Cruzeiro/BRA/55 capsid-based subunit vaccine (AdtA24). In two independent vaccine efficacy trials, AdtA24 was administered once intramuscularly in the neck 7 days prior to contact with FMDV A24/Cruzeiro/BRA/55-infected seeder steers. RESULTS: In Efficacy Study 1, we evaluated three doses of AdtA24 to estimate the 50%/90% bovine protective dose (BPD(50/90)) for prevention of clinical FMD. In vaccinated, contact-challenged steers, the BPD(50/90) was 3.1 × 10(10) / 5.5 × 10(10) AdtA24 particles formulated without adjuvant. In Efficacy Study 2, steers vaccinated with 5 × 10(10) AdtA24 particles, exposed to FMDV A24/Cruzeiro/BRA/55-infected seeder steers, did not develop clinical FMD or transmit FMDV to other vaccinated or naïve, non-vaccinated steers. In contrast, naïve, non-vaccinated steers that were subsequently exposed to FMDV A24/Cruzeiro/BRA/55-infected seeder steers developed clinical FMD and transmitted FMDV by contact to additional naïve, non-vaccinated steers. The AdtA24 vaccine differentiated infected from vaccinated animals (DIVA) because no antibodies to FMDV nonstructural proteins were detected prior to FMDV exposure. CONCLUSIONS: A single dose of the AdtA24 non-adjuvanted vaccine conferred protection against clinical FMD at 7 days post-vaccination following direct contact transmission from FMDV-infected, naïve, non-vaccinated steers. The AdtA24 vaccine was effective in preventing FMDV transmission from homologous challenged, contact-exposed, AdtA24-vaccinated, protected steers to co-mingled, susceptible steers, suggesting that the vaccine may be beneficial in reducing both the magnitude and duration of a FMDV outbreak in a commercial cattle production setting. BioMed Central 2018-08-29 /pmc/articles/PMC6114537/ /pubmed/30157853 http://dx.doi.org/10.1186/s12917-018-1582-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Neilan, John G. Schutta, Christopher Barrera, José Pisano, Melia Zsak, Laszlo Hartwig, Ethan Rasmussen, Max V. Kamicker, Barbara J. Ettyreddy, Damodar Brough, Douglas E. Butman, Bryan T. Brake, David A. Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model |
title | Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model |
title_full | Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model |
title_fullStr | Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model |
title_full_unstemmed | Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model |
title_short | Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model |
title_sort | efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype a subunit vaccine in cattle using a direct contact transmission model |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114537/ https://www.ncbi.nlm.nih.gov/pubmed/30157853 http://dx.doi.org/10.1186/s12917-018-1582-1 |
work_keys_str_mv | AT neilanjohng efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel AT schuttachristopher efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel AT barrerajose efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel AT pisanomelia efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel AT zsaklaszlo efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel AT hartwigethan efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel AT rasmussenmaxv efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel AT kamickerbarbaraj efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel AT ettyreddydamodar efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel AT broughdouglase efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel AT butmanbryant efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel AT brakedavida efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel |